組換えタンパク質の世界市場 2023-2027

当レポートでは、組換えタンパク質の市場規模は、2022年から2027年の間に6億5,096万米ドル、予測期間中のCAGRは9.46%で成長すると予測しています。

当レポートでは、組換えタンパク質市場について、全体的な分析、市場規模と予測、動向、成長促進要因・課題、さらに約25のベンダーを網羅したベンダー分析を行っています。

現在の市場シナリオ、最新動向と促進要因、市場環境全般に関する最新の分析を提供しています。市場は、慢性疾患の増加、生物製剤やバイオシミラーへの傾倒の高まり、組換えタンパク質の生産における技術的進歩によって牽引されています。

本調査では、今後数年間の組換えタンパク質市場の成長を促進する主な理由の一つとして、ベンダーによる共同研究や戦略的提携の増加を挙げています。また、R&Dへの支出の増加や新興国からの機会の増加は、市場の大きな需要につながるでしょう。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場別分析
• 市場規模 2022
• 市場の見通し 2022-2027

第4章 市場規模実績

• 組換えタンパク質の世界市場 2017-2021
• 用途別分析 2017-2021
• エンドユーザーセグメント分析 2017-2021
• 地域別分析 2017-2021
• 国別分析 2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：用途別

• 市場セグメント
• 比較：用途別
• バイオテクノロジー研究：市場規模と予測 2022-2027
• 創薬と開発：市場規模と予測 2022-2027
• バイオ医薬品の生産：市場規模と予測 2022-2027
• その他：市場規模と予測 2022-2027
• 市場機会：用途別

第7章 市場セグメンテーション：エンドユーザー別

• 市場セグメント
• 比較：エンドユーザー別
• 製薬会社およびバイオテクノロジー会社：市場規模と予測 2022-2027
• 学術研究機関：市場規模と予測 2022-2027
• その他：市場規模と予測 2022-2027
• 市場機会：エンドユーザー別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2022-2027
• 欧州：市場規模と予測 2022-2027
• アジア：市場規模と予測 2022-2027
• 世界のその他の地域：市場規模と予測 2022-2027
• 米国：市場規模と予測 2022-2027
• 中国：市場規模と予測 2022-2027
• ドイツ：市場規模と予測 2022-2027
• イタリア：市場規模と予測 2022-2027
• 日本：市場規模と予測 2022-2027
• 地域情勢別市場機会

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Abcam plc
• Amgen Inc.
• Aviva Systems Biology Corp.
• Bio Rad Laboratories Inc.
• BPS Bioscience Inc.
• Enzo Biochem Inc.
• GenScript Biotech Corp.
• Merck KGaA
• Novartis AG
• Novo Nordisk AS
• Prospec Tany Technogene Ltd.
• Proteintech Group Inc.
• Sanofi SA
• Sino Biological Inc.
• Thermo Fisher Scientific Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Application
• Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on global recombinant proteins market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Application - Market share 2022-2027 (%)
• Exhibits31: Data Table on Application - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Application
• Exhibits33: Data Table on Comparison by Application
• Exhibits34: Chart on Biotechnology research - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Biotechnology research - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Biotechnology research - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Biotechnology research - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Drug discovery and development - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Drug discovery and development - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Drug discovery and development - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Drug discovery and development - Year-over-year growth 2022-2027 (%)
• Exhibits42: Chart on Biopharmaceutical production - Market size and forecast 2022-2027 ($ million)
• Exhibits43: Data Table on Biopharmaceutical production - Market size and forecast 2022-2027 ($ million)
• Exhibits44: Chart on Biopharmaceutical production - Year-over-year growth 2022-2027 (%)
• Exhibits45: Data Table on Biopharmaceutical production - Year-over-year growth 2022-2027 (%)
• Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%)
• Exhibits50: Market opportunity by Application ($ million)
• Exhibits51: Data Table on Market opportunity by Application ($ million)
• Exhibits52: Chart on End-user - Market share 2022-2027 (%)
• Exhibits53: Data Table on End-user - Market share 2022-2027 (%)
• Exhibits54: Chart on Comparison by End-user
• Exhibits55: Data Table on Comparison by End-user
• Exhibits56: Chart on Pharma and biotechnology companies - Market size and forecast 2022-2027 ($ million)
• Exhibits57: Data Table on Pharma and biotechnology companies - Market size and forecast 2022-2027 ($ million)
• Exhibits58: Chart on Pharma and biotechnology companies - Year-over-year growth 2022-2027 (%)
• Exhibits59: Data Table on Pharma and biotechnology companies - Year-over-year growth 2022-2027 (%)
• Exhibits60: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
• Exhibits61: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
• Exhibits62: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%)
• Exhibits63: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%)
• Exhibits64: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits65: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibits66: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibits67: Data Table on Others - Year-over-year growth 2022-2027 (%)
• Exhibits68: Market opportunity by End-user ($ million)
• Exhibits69: Data Table on Market opportunity by End-user ($ million)
• Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits71: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits73: Chart on Geographic comparison
• Exhibits74: Data Table on Geographic comparison
• Exhibits75: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits77: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits78: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits81: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits85: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits91: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits92: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits93: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits94: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits95: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibits96: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibits97: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits98: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits101: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits103: Chart on Italy - Market size and forecast 2022-2027 ($ million)
• Exhibits104: Data Table on Italy - Market size and forecast 2022-2027 ($ million)
• Exhibits105: Chart on Italy - Year-over-year growth 2022-2027 (%)
• Exhibits106: Data Table on Italy - Year-over-year growth 2022-2027 (%)
• Exhibits107: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibits108: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibits109: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits110: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits111: Market opportunity By Geographical Landscape ($ million)
• Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits113: Impact of drivers and challenges in 2022 and 2027
• Exhibits114: Overview on Criticality of inputs and Factors of differentiation
• Exhibits115: Overview on factors of disruption
• Exhibits116: Impact of key risks on business
• Exhibits117: Vendors covered
• Exhibits118: Matrix on vendor position and classification
• Exhibits119: Abcam plc - Overview
• Exhibits120: Abcam plc - Product / Service
• Exhibits121: Abcam plc - Key news
• Exhibits122: Abcam plc - Key offerings
• Exhibits123: Amgen Inc. - Overview
• Exhibits124: Amgen Inc. - Product / Service
• Exhibits125: Amgen Inc. - Key offerings
• Exhibits126: Aviva Systems Biology Corp. - Overview
• Exhibits127: Aviva Systems Biology Corp. - Product / Service
• Exhibits128: Aviva Systems Biology Corp. - Key offerings
• Exhibits129: Bio Rad Laboratories Inc. - Overview
• Exhibits130: Bio Rad Laboratories Inc. - Business segments
• Exhibits131: Bio Rad Laboratories Inc. - Key news
• Exhibits132: Bio Rad Laboratories Inc. - Key offerings
• Exhibits133: Bio Rad Laboratories Inc. - Segment focus
• Exhibits134: BPS Bioscience Inc. - Overview
• Exhibits135: BPS Bioscience Inc. - Product / Service
• Exhibits136: BPS Bioscience Inc. - Key offerings
• Exhibits137: Enzo Biochem Inc. - Overview
• Exhibits138: Enzo Biochem Inc. - Product / Service
• Exhibits139: Enzo Biochem Inc. - Key offerings
• Exhibits140: GenScript Biotech Corp. - Overview
• Exhibits141: GenScript Biotech Corp. - Business segments
• Exhibits142: GenScript Biotech Corp. - Key news
• Exhibits143: GenScript Biotech Corp. - Key offerings
• Exhibits144: GenScript Biotech Corp. - Segment focus
• Exhibits145: Merck KGaA - Overview
• Exhibits146: Merck KGaA - Business segments
• Exhibits147: Merck KGaA - Key news
• Exhibits148: Merck KGaA - Key offerings
• Exhibits149: Merck KGaA - Segment focus
• Exhibits150: Novartis AG - Overview
• Exhibits151: Novartis AG - Business segments
• Exhibits152: Novartis AG - Key offerings
• Exhibits153: Novartis AG - Segment focus
• Exhibits154: Novo Nordisk AS - Overview
• Exhibits155: Novo Nordisk AS - Business segments
• Exhibits156: Novo Nordisk AS - Key offerings
• Exhibits157: Novo Nordisk AS - Segment focus
• Exhibits158: Prospec Tany Technogene Ltd. - Overview
• Exhibits159: Prospec Tany Technogene Ltd. - Product / Service
• Exhibits160: Prospec Tany Technogene Ltd. - Key offerings
• Exhibits161: Proteintech Group Inc. - Overview
• Exhibits162: Proteintech Group Inc. - Product / Service
• Exhibits163: Proteintech Group Inc. - Key offerings
• Exhibits164: Sanofi SA - Overview
• Exhibits165: Sanofi SA - Business segments
• Exhibits166: Sanofi SA - Key news
• Exhibits167: Sanofi SA - Key offerings
• Exhibits168: Sanofi SA - Segment focus
• Exhibits169: Sino Biological Inc. - Overview
• Exhibits170: Sino Biological Inc. - Product / Service
• Exhibits171: Sino Biological Inc. - Key offerings
• Exhibits172: Thermo Fisher Scientific Inc. - Overview
• Exhibits173: Thermo Fisher Scientific Inc. - Business segments
• Exhibits174: Thermo Fisher Scientific Inc. - Key news
• Exhibits175: Thermo Fisher Scientific Inc. - Key offerings
• Exhibits176: Thermo Fisher Scientific Inc. - Segment focus
• Exhibits177: Inclusions checklist
• Exhibits178: Exclusions checklist
• Exhibits179: Currency conversion rates for US$
• Exhibits180: Research methodology
• Exhibits181: Validation techniques employed for market sizing
• Exhibits182: Information sources
• Exhibits183: List of abbreviations

Technavio has been monitoring the recombinant proteins market and is forecast to grow by USD 650.96 mn during 2022-2027, accelerating at a CAGR of 9.46% during the forecast period. Our report on the recombinant proteins market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in chronic diseases, rising inclination toward biologics and biosimilars, and technological advancements in production of recombinant proteins.

Technavio's recombinant proteins market is segmented as below:

By Application

• Biotechnology research
• Drug discovery and development
• Biopharmaceutical production
• Others

By End-user

• Pharma and biotechnology companies
• Academic and research institutes
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increase in collaborations and strategic alliances by vendors as one of the prime reasons driving the recombinant proteins market growth during the next few years. Also, increased expenditure on R and D and growing opportunities from emerging economies will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the recombinant proteins market covers the following areas:

• Recombinant proteins market sizing
• Recombinant proteins market forecast
• Recombinant proteins market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading recombinant proteins market vendors that include Abcam plc, Airway Therapeutics Inc., Amgen Inc., Aviva Systems Biology Corp., Bio Techne Corp., Bio Rad Laboratories Inc., BPS Bioscience Inc., Elabscience Biotechnology Inc., Enzo Biochem Inc., GenScript Biotech Corp., Grifols SA, Merck KGaA, Novartis AG, Novo Nordisk AS, OriGene Technologies Inc., Prospec Tany Technogene Ltd., Proteintech Group Inc., Sanofi SA, Sino Biological Inc., and Thermo Fisher Scientific Inc. Also, the recombinant proteins market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global recombinant proteins market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on global recombinant proteins market 2017 - 2021 ($ million)
• 4.2 Application Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
• 4.3 End-user Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

• 6.1 Market segments
• Exhibit 30: Chart on Application - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
• 6.2 Comparison by Application
• Exhibit 32: Chart on Comparison by Application
• Exhibit 33: Data Table on Comparison by Application
• 6.3 Biotechnology research - Market size and forecast 2022-2027
• Exhibit 34: Chart on Biotechnology research - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Biotechnology research - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Biotechnology research - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Biotechnology research - Year-over-year growth 2022-2027 (%)
• 6.4 Drug discovery and development - Market size and forecast 2022-2027
• Exhibit 38: Chart on Drug discovery and development - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Drug discovery and development - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Drug discovery and development - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Drug discovery and development - Year-over-year growth 2022-2027 (%)
• 6.5 Biopharmaceutical production - Market size and forecast 2022-2027
• Exhibit 42: Chart on Biopharmaceutical production - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Biopharmaceutical production - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Biopharmaceutical production - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Biopharmaceutical production - Year-over-year growth 2022-2027 (%)
• 6.6 Others - Market size and forecast 2022-2027
• Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
• 6.7 Market opportunity by Application
• Exhibit 50: Market opportunity by Application ($ million)
• Exhibit 51: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by End-user

• 7.1 Market segments
• Exhibit 52: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 53: Data Table on End-user - Market share 2022-2027 (%)
• 7.2 Comparison by End-user
• Exhibit 54: Chart on Comparison by End-user
• Exhibit 55: Data Table on Comparison by End-user
• 7.3 Pharma and biotechnology companies - Market size and forecast 2022-2027
• Exhibit 56: Chart on Pharma and biotechnology companies - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Pharma and biotechnology companies - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Pharma and biotechnology companies - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Pharma and biotechnology companies - Year-over-year growth 2022-2027 (%)
• 7.4 Academic and research institutes - Market size and forecast 2022-2027
• Exhibit 60: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%)
• 7.5 Others - Market size and forecast 2022-2027
• Exhibit 64: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 67: Data Table on Others - Year-over-year growth 2022-2027 (%)
• 7.6 Market opportunity by End-user
• Exhibit 68: Market opportunity by End-user ($ million)
• Exhibit 69: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 73: Chart on Geographic comparison
• Exhibit 74: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 China - Market size and forecast 2022-2027
• Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.9 Germany - Market size and forecast 2022-2027
• Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.10 Italy - Market size and forecast 2022-2027
• Exhibit 103: Chart on Italy - Market size and forecast 2022-2027 ($ million)
• Exhibit 104: Data Table on Italy - Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Chart on Italy - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on Italy - Year-over-year growth 2022-2027 (%)
• 9.11 Japan - Market size and forecast 2022-2027
• Exhibit 107: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 108: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 109: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 110: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 111: Market opportunity By Geographical Landscape ($ million)
• Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 113: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 115: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 116: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 117: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 118: Matrix on vendor position and classification
• 12.3 Abcam plc
• Exhibit 119: Abcam plc - Overview
• Exhibit 120: Abcam plc - Product / Service
• Exhibit 121: Abcam plc - Key news
• Exhibit 122: Abcam plc - Key offerings
• 12.4 Amgen Inc.
• Exhibit 123: Amgen Inc. - Overview
• Exhibit 124: Amgen Inc. - Product / Service
• Exhibit 125: Amgen Inc. - Key offerings
• 12.5 Aviva Systems Biology Corp.
• Exhibit 126: Aviva Systems Biology Corp. - Overview
• Exhibit 127: Aviva Systems Biology Corp. - Product / Service
• Exhibit 128: Aviva Systems Biology Corp. - Key offerings
• 12.6 Bio Rad Laboratories Inc.
• Exhibit 129: Bio Rad Laboratories Inc. - Overview
• Exhibit 130: Bio Rad Laboratories Inc. - Business segments
• Exhibit 131: Bio Rad Laboratories Inc. - Key news
• Exhibit 132: Bio Rad Laboratories Inc. - Key offerings
• Exhibit 133: Bio Rad Laboratories Inc. - Segment focus
• 12.7 BPS Bioscience Inc.
• Exhibit 134: BPS Bioscience Inc. - Overview
• Exhibit 135: BPS Bioscience Inc. - Product / Service
• Exhibit 136: BPS Bioscience Inc. - Key offerings
• 12.8 Enzo Biochem Inc.
• Exhibit 137: Enzo Biochem Inc. - Overview
• Exhibit 138: Enzo Biochem Inc. - Product / Service
• Exhibit 139: Enzo Biochem Inc. - Key offerings
• 12.9 GenScript Biotech Corp.
• Exhibit 140: GenScript Biotech Corp. - Overview
• Exhibit 141: GenScript Biotech Corp. - Business segments
• Exhibit 142: GenScript Biotech Corp. - Key news
• Exhibit 143: GenScript Biotech Corp. - Key offerings
• Exhibit 144: GenScript Biotech Corp. - Segment focus
• 12.10 Merck KGaA
• Exhibit 145: Merck KGaA - Overview
• Exhibit 146: Merck KGaA - Business segments
• Exhibit 147: Merck KGaA - Key news
• Exhibit 148: Merck KGaA - Key offerings
• Exhibit 149: Merck KGaA - Segment focus
• 12.11 Novartis AG
• Exhibit 150: Novartis AG - Overview
• Exhibit 151: Novartis AG - Business segments
• Exhibit 152: Novartis AG - Key offerings
• Exhibit 153: Novartis AG - Segment focus
• 12.12 Novo Nordisk AS
• Exhibit 154: Novo Nordisk AS - Overview
• Exhibit 155: Novo Nordisk AS - Business segments
• Exhibit 156: Novo Nordisk AS - Key offerings
• Exhibit 157: Novo Nordisk AS - Segment focus
• 12.13 Prospec Tany Technogene Ltd.
• Exhibit 158: Prospec Tany Technogene Ltd. - Overview
• Exhibit 159: Prospec Tany Technogene Ltd. - Product / Service
• Exhibit 160: Prospec Tany Technogene Ltd. - Key offerings
• 12.14 Proteintech Group Inc.
• Exhibit 161: Proteintech Group Inc. - Overview
• Exhibit 162: Proteintech Group Inc. - Product / Service
• Exhibit 163: Proteintech Group Inc. - Key offerings
• 12.15 Sanofi SA
• Exhibit 164: Sanofi SA - Overview
• Exhibit 165: Sanofi SA - Business segments
• Exhibit 166: Sanofi SA - Key news
• Exhibit 167: Sanofi SA - Key offerings
• Exhibit 168: Sanofi SA - Segment focus
• 12.16 Sino Biological Inc.
• Exhibit 169: Sino Biological Inc. - Overview
• Exhibit 170: Sino Biological Inc. - Product / Service
• Exhibit 171: Sino Biological Inc. - Key offerings
• 12.17 Thermo Fisher Scientific Inc.
• Exhibit 172: Thermo Fisher Scientific Inc. - Overview
• Exhibit 173: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 174: Thermo Fisher Scientific Inc. - Key news
• Exhibit 175: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 176: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 177: Inclusions checklist
• Exhibit 178: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 179: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 180: Research methodology
• Exhibit 181: Validation techniques employed for market sizing
• Exhibit 182: Information sources
• 13.5 List of abbreviations
• Exhibit 183: List of abbreviations